Utilising artificial intelligence (AI) for analysing multiplex genomic and magnetic resonance imaging (MRI) data to develop multimodality predictive system for personalised neoadjuvant treatment of breast cancer (BC)

Category Primary study
JournalCancer Research
Year 2022
This article has no abstract
Epistemonikos ID: 66aac571ba483fb512c2942cbf293fd568315914
First added on: Feb 14, 2025